Stericycle (SRCL) Stock Price, News & Analysis

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last twelve months. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SRCL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SRCL, but not buy additional shares or sell existing shares.
View SRCL analyst ratings or view top-rated stocks.

4 equities research analysts have issued 12 month price objectives for Stericycle's stock. Their SRCL share price targets range from $48.00 to $75.00. On average, they predict the company's share price to reach $62.25 in the next twelve months. This suggests a possible upside of 27.1% from the stock's current price.
View analysts price targets for SRCL or view top-rated stocks among Wall Street analysts.

Stericycle's stock was trading at $49.56 at the start of the year. Since then, SRCL stock has decreased by 1.2% and is now trading at $48.97.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our SRCL earnings forecast.

Stericycle, Inc. (NASDAQ:SRCL) released its earnings results on Wednesday, February, 28th. The business services provider reported $0.54 EPS for the quarter, topping the consensus estimate of $0.47 by $0.07. The business services provider earned $652 million during the quarter, compared to analysts' expectations of $657.99 million. Stericycle had a positive trailing twelve-month return on equity of 7.06% and a negative net margin of 0.80%. The firm's revenue was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.60 earnings per share.

ETFs with the largest weight of Stericycle (NASDAQ:SRCL) stock in their portfolio include VanEck Environmental Services ETF (EVX), Ecofin U.S. Renewables Infrastructure Trust (RNEW), iShares Environmental Infrastructure and Industrials ETF (EFRA), QRAFT AI-Enhanced U.S. Next Value ETF (NVQ), First Trust Utilities AlphaDEX Fund (FXU) and iShares U.S. Utilities ETF (IDU).Pacer BioThreat Strategy ETF (VIRS) and

Stericycle updated its FY24 earnings guidance on Tuesday, March, 5th. The company provided EPS guidance of $2.20-2.50 for the period, compared to the consensus earnings per share estimate of $2.34.

132 employees have rated Stericycle Chief Executive Officer Cindy Miller on Glassdoor.com. Cindy Miller has an approval rating of 74% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Stericycle investors own include Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Starbucks (SBUX), Walt Disney (DIS), QUALCOMM (QCOM), Johnson & Johnson (JNJ), AbbVie (ABBV), Fastenal (FAST) and Gilead Sciences (GILD).

Stericycle's stock is owned by a variety of retail and institutional investors. Top institutional investors include Perpetual Ltd (0.30%), Park Avenue Securities LLC (0.01%) and GAMMA Investing LLC (0.00%). Insiders that own company stock include Daniel Ginnetti, Naren K Gursahaney and Stephen Cory White.
View institutional ownership trends.

Shares of SRCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.